• Perceived Importance of the Benefits and Harms of Colorectal Cancer Screening: A Best-Worst Scaling Study

    Jun 1, 2023, 00:00
  • HPR21 Implementation Challenges and Real-World Impacts of Switching Pediatric Vaccines: A Global Systematic Literature Review

    Jun 1, 2023, 00:00
  • RWD69 5-Year Graft Failure Outcomes Utilizing Kidneys with Higher Kidney Donor Profile Index Scores across Different Age Groups and Sex over a 10-Year Period

    Jun 1, 2023, 00:00
  • EE393 Ovarian Cancer Overview: Treatments and Costs in the Brazilian Outpatient Public Settings – A Claim Database (DATASUS) Study

    Jun 1, 2023, 00:00
  • CO123 Health-Related Quality of Life (HRQOL) Among Mucopolysaccharidoses (MPS) Patients Receiving Enzyme Replacement Therapy (ERT): A Systematic Literature Review

    Jun 1, 2023, 00:00
  • HTA87 Caplacizumab for the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (ATTP): Technology Qualification in Colombia

    Jun 1, 2023, 00:00
  • EPH47 Active Surveillance for Safety Monitoring of COVID-19 Vaccines in Saudi Arabia

    Jun 1, 2023, 00:00
  • EE132 Cost-Utility Analysis of Long-Acting Injectable (1-, 3-, AND 6-MONTH INJECTION) and Oral Paliperidone in Adults with Stable Schizophrenia

    Jun 1, 2023, 00:00
  • MSR92 Racial and Smoking Status Disparities in Mediation Effects on Liraglutide-Associated Cardiovascular Outcomes: A Dynamic Path Analysis Using Leader Trial Data

    Jun 1, 2023, 00:00
  • EE513 Economic Evaluation of Universal Lynch Syndrome Screening Protocols Among Newly Diagnosed Patients with Endometrial Cancer

    Jun 1, 2023, 00:00
  • HTA83 Investigating the Net Benefit of a Clinical Algorithm Detecting Chemotherapy Patients’ Risk of Emergency Care and Inpatient Hospitalization

    Jun 1, 2023, 00:00
  • EE413 The Cost of Accessing Abortion Services in Ghana: An Implication on Safe Abortion Uptake

    Jun 1, 2023, 00:00
  • CO122 Late-Onset Pompe Disease (LOPD) Patients Treated with Avalglucosidase Alfa Show Favorable Results Compared to Cipaglucosidase Alfa Plus Miglustat: Indirect Treatment Comparison

    Jun 1, 2023, 00:00
  • EE348 Real-World Analysis of Dental Utilization and Costs Among Type I and Type II Diabetics

    Jun 1, 2023, 00:00
  • CO132 Predictive Validity of Pt-Global Web-Tool/PG-SGA, and Impact of Malnutrition on Renal Outcomes in Chronic Kidney Disease Patients: A Hospital-Based Prospective Cohort

    Jun 1, 2023, 00:00
  • RWD99 The Clinical Burden of Friedreich Ataxia: A Retrospective Claims Analysis in the United States

    Jun 1, 2023, 00:00
  • EPH197 Using High Quality Open Data to Find Long Term Results in an Continuously Enrolled Population, an Example in BPH

    Jun 1, 2023, 00:00
  • SA20 The Potential of Real-World Evidence to Complement Basket Trials for Tissue Agnostic Drugs Targeting Neurotrophic Tropomyosin-Related Kinase Gene Fusions

    Jun 1, 2023, 00:00
  • RWD22 A Novel Patient-Centered Real-World Evidence Study Designed to Better Understand Chronic Inflammatory Demyelinating Polyneuropathy Using Longitudinal Data in the United States

    Jun 1, 2023, 00:00
  • PCR81 The Economic Burden of Individuals Living with Generalized Myasthenia Gravis and Social Determinants of Health Barriers

    Jun 1, 2023, 00:00
  • EE43 Health Care Resource Utilization (HCRU) and Costs of First-Line Systemic Therapy (1LT) for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (a/mNSCLC) - A Secondary Analysis of Claims Data from the United States (US)

    Jun 1, 2023, 00:00
  • RWD119 Real-World Evidence on the Association between the Use of Cannabis and Healthcare Resource Utilization Among Patients with Chronic Post-Traumatic Stress Disorder

    Jun 1, 2023, 00:00
  • EE259 Burden of Essential Tremor: Associated Morbidities, Healthcare Resource Utilization and Costs in Medicare Beneficiaries on Drug Therapy

    Jun 1, 2023, 00:00
  • RWD90 Impact of Relaxing Brain Metastases Exclusion Criteria on Colon Cancer Trials Population

    Jun 1, 2023, 00:00
  • RWD15 Epidemiology Description, Treatment Patterns, Resource Utilization and Biomarker Testing of Metastatic Triple Negative Breast Cancer (TNBC) Patients in Costa Rica

    Jun 1, 2023, 00:00
  • PCR179 Patient Preferences in Pulmonary Arterial Hypertension (PAH), a Latent Class Analysis to Identify Preference Heterogeneity

    Jun 1, 2023, 00:00
  • EE502 Medical Expenditures Among Cancer Patients in the United States: Estimates from Medical Expenditure Panel Survey (MEPS) Data

    Jun 1, 2023, 00:00
  • PCR29 Sustained Humanistic Burden and Work Impact in Adults with Transfusion-Dependent Beta-Thalassemia (TDT): Results from a Global Longitudinal Survey

    Jun 1, 2023, 00:00
  • EE257 Cost Effectiveness Analysis of Qulipta in Episodic Migraine Prophylaxis

    Jun 1, 2023, 00:00
  • SA13 The Effect of Treatment Discontinuation Definitions on Estimates of Treatment Persistence – A Multi-Indication Study with Health Insurance Claims Data

    Jun 1, 2023, 00:00
  • HSD38 Operational Savings Generated in an Integrated Care Program for Patients with Complex Respiratory Diseases

    Jun 1, 2023, 00:00
  • EE244 Cost-Effectiveness Analysis of Liposomal Amphotericin B Versus Isavuconazole for Treating Mucormycosis in the Consolidation Phase from the Perspective of the Brazilian Unified Health System

    Jun 1, 2023, 00:00
  • OP12 Reconciling Standardisation Processes and Improvisation Practices in Health Care: How to Deal with Structural, Clinical and Performative Unpredictability

    Jun 1, 2023, 00:00
  • HSD12 Measuring Psoriasis Disease Activity in the Real-World Setting: Relationship between the Physician Global Assessment and Body Surface Area Product and the Psoriasis Area and Severity Index

    Jun 1, 2023, 00:00
  • CO93 A Qualitative Investigation of the Impact of the Sars-Cov-2 Pandemic on Goal Attainment Scaling in a Clinical Research Setting

    Jun 1, 2023, 00:00
  • MSR21 Impact of Correlated Outcomes in Probabilistic Sensitivity Analyses When Treatment Effects Are Derived from a Network Meta-Analysis

    Jun 1, 2023, 00:00
  • HSD36 Economic Burden of Newly Diagnosed Patients with Plantar Fibromatosis (PF) in the United States (US)

    Jun 1, 2023, 00:00
  • HTA36 The First Managed Entry Agreements Based on Health Technology Assessment Approved in Ukraine: Analysis and Future Perspectives

    Jun 1, 2023, 00:00
  • HTA96 Applying Early Health Technology Assessments to Inform Novel Health Technology Innovation

    Jun 1, 2023, 00:00
  • HTA75 Prioritized Attributes to Better Define and Measure Innovation in Health Technology Assessment: Findings from an Expert Roundtable

    Jun 1, 2023, 00:00
  • MT40 Comparing Resource Consumption from an Economic Evaluation of Gore® Viatorr® Tips Endoprosthesis Versus Large Volume Paracentesis in the Spanish and U.K. Healthcare Systems

    Jun 1, 2023, 00:00
  • EPH42 Long Working Hours and the Use of Prescription Sedatives Among the U.S. Labor Force

    Jun 1, 2023, 00:00
  • EE130 Years of Potential Life Lost with Premature Mortality Caused By Injury in Mongolia

    Jun 1, 2023, 00:00
  • MSR77 Making a Case for Case Reports: A Scoping Review of the Use of and Challenges with Case Report Data in Quantitative Synthesis

    Jun 1, 2023, 00:00
  • RWD104 Generalization of the Effectiveness of Baricitinib 4MG Among bDMARD-IR Rheumatoid Arthritis Patients from a RCT to a Real-World Population in China

    Jun 1, 2023, 00:00
  • HPR138 The Squeezed Middle - Sociodemographic Disparities in Prostate Cancer Presentation in Ireland - Results from the Irish Prostate Cancer Outcomes Research (IPCOR) Study

    Jun 1, 2023, 00:00
  • PCR108 The Effect of Team Incentives on Medication Adheren Design of a Randomized Controlled Trial

    Jun 1, 2023, 00:00
  • EE211 Guidelines for the Economic Evaluation of Vaccination Programs in Canada

    Jun 1, 2023, 00:00
  • EE199 Cost-Effectiveness of Pembrolizumab for the First-Line Treatment of Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma in Colombia

    Jun 1, 2023, 00:00
  • CO96 Comparative Efficacy of Pharmacological Interventions for Heart Failure with Reduced Ejection Fraction between Asian and White Patients: A Meta-Analysis of Randomized Outcomes Trials

    Jun 1, 2023, 00:00
  • HPR38 Assessing the Usability of Insurance Payment Rate Data Under the Price Transparency Rules: A Case Study of Ohio Mental and Behavioral Health Services

    Jun 1, 2023, 00:00
  • PCR157 Sociopsychological Factors Related to Information Seeking during the COVID-19 Pandemic

    Jun 1, 2023, 00:00
  • HPR84 Pre-Approval Information Exchange (PIE). Are US Healthcare Decision Makers and Manufacturers Both Getting a Piece of the Pie?

    Jun 1, 2023, 00:00
  • HPR34 Impact of the Inflation Reduction Act on Pricing, Reimbursement, and Market Access in the US

    Jun 1, 2023, 00:00
  • EE396 Cost-Effectiveness of Gleolan Guided Surgery Compared to Conventional White Light Surgery for High Grade Glioma

    Jun 1, 2023, 00:00
  • EE352 Diabetes Mellitus in Argentina: A Systematic Review for Constructing Its Economic Profile

    Jun 1, 2023, 00:00
  • EE25 A Systematic Literature Review to Assess the Modeling Approaches in Economic Evaluations of Health Interventions for Adult Binge Eating Disorders

    Jun 1, 2023, 00:00
  • HPR29 Health Equity Frameworks – Healthcare System Actions and Priorities

    Jun 1, 2023, 00:00
  • RWD103 Comparative Effectiveness of a Bilayered Living Cellular Construct and a Cryopreserved Cadaveric Skin Allograft for Use in Venous Leg Ulcers

    Jun 1, 2023, 00:00
  • EE72 A Value Pyramid to Guide Asthma Interventions in the UK

    Jun 1, 2023, 00:00
  • EE450 Assessment of the Quality of Time-Driven Activity-Based Costing (TDABC) Studies on Cardiovascular Diseases and Oncology

    Jun 1, 2023, 00:00
  • CO187 The Framing of Time-Dependent Machine Learning Models Improves Risk Estimation Among Young Individuals with Acute Coronary Syndromes

    Jun 1, 2023, 00:00
  • HTA69 Towards a Minimum Information Set Needed to Define Patient-Facing Digital Health Technology for Outcomes Research

    Jun 1, 2023, 00:00
  • P51 Evaluating the Patient Experience with CD55 Deficiency with Hyperactivation of Complement, Angiopathic Thrombosis, and Protein-Losing Enteropathy (CHAPLE) Disease: A Deadly Ultra-Rare Pediatric Disease

    Jun 1, 2023, 00:00
  • SA5 Defining Colorectal Cancer Recurrence with Structured-Health Data Algorithms: A Targeted Literature Review

    Jun 1, 2023, 00:00
  • Table of Contents

    Jun 1, 2023, 00:00
  • PCR244 Validity of the EQ Health and Wellbeing Experimental Version (LONG AND SHORT) in the Italian Population

    Jun 1, 2023, 00:00
  • EE212 Comprehensive Review of Methods to Estimate Market Share Uptakes in Budget Impact Models

    Jun 1, 2023, 00:00
  • SA48 Do 30-Day Out-of-Pocket Costs Influence Rifaximin Treatment Retention in Patients with Hepatic Encephalopathy?

    Jun 1, 2023, 00:00
  • CO72 Risk of Richter Transformation in Relapsed/Refractory Cll: Results of Bayesian Network Meta-Analysis

    Jun 1, 2023, 00:00
  • PCR237 Evaluating the Psychometric Properties of a Questionnaire Designed to Assess Headache Characteristics and Management Among United States Student Pharmacists

    Jun 1, 2023, 00:00
  • SA35 Prognostic Factors and Effect Modifiers in Patients with Relapsed or Refractory Follicular Lymphoma Who Failed at Least 2 Lines of Therapy: A Systematic Literature Review

    Jun 1, 2023, 00:00
  • EE369 Soothing the Soul: Cost-Effectiveness Evaluation of Group Music Therapy in Reducing Clinically-Significant Agitation Among People with Dementia

    Jun 1, 2023, 00:00
  • EE323 Implications for Utilizing a Female External Catheter (FEC) in End-of-Life Patients – Model of the Potential Impact upon Informal, Unpaid Caregiver (IUC) Burden in the Community Setting

    Jun 1, 2023, 00:00
  • PCR226 Symptoms, Treatment Effectiveness and Quality of Life for Patients Living with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) in the United States: Patient and Caregiver Reported Outcomes from LC-FAOD Odyssey

    Jun 1, 2023, 00:00
  • RWD182 Influence of Multiple Instance Learning on the Generation of Computational Pathology Algorithms and Its Value-Based Impact

    Jun 1, 2023, 00:00
  • EE112 Budget Impact Analysis of Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low, Intermediate, and High-Risk Patients with Severe, Symptomatic Aortic Stenosis in the United States

    Jun 1, 2023, 00:00
  • HSD90 Value as the Next Innovation in Rectal Cancer Surgery: A Review

    Jun 1, 2023, 00:00
  • PCR90 Pilot Testing a Patient-Driven Discrete Choice Experiment Instrument for Patients with Chronic Obstructive Pulmonary Disease: Methods and Qualitative Results

    Jun 1, 2023, 00:00
  • Health Service Delivery Process of Care

    Jun 1, 2023, 00:00
  • EE524 Validity and Reliability of the EQ-5D-5L and Propr in Patients with Spinal Muscular Atrophy

    Jun 1, 2023, 00:00
  • EE275 Budget Impact of a Blood-Based Auto-Antibody Test to up-Classify Risk of Pulmonary Nodules in a US Commercial Payer Setting

    Jun 1, 2023, 00:00
  • HTA74 HTA Processes for Medical Technologies across the World – Are All Hurdles the Same?

    Jun 1, 2023, 00:00
  • MSR82 A Methodological Framework to Conduct Data Sources Landscaping for Real-World Studies (RWS)

    Jun 1, 2023, 00:00
  • PCR85 Sustained Humanistic Burden and Work Impact in Adults with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises: Results from a Global Longitudinal Survey

    Jun 1, 2023, 00:00
  • HPR135 Inflation Reduction Act (IRA) Impact: Medicare Part D Beneficiaries Out-of-Pocket Spending on Insulin

    Jun 1, 2023, 00:00
  • EE311 Burden of Disease of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) Using the Standard of Care in Central America

    Jun 1, 2023, 00:00
  • CO223 The Use of Artificial Intelligence to Guide Medication Dosage Is Associated with Improved Anemia Management and Lower Erythropoietin Stimulating Agents Consumption Among Dialysis Patients

    Jun 1, 2023, 00:00
  • OP19 Early Detection of High-Risk Pregnancy for Blue and Cross Blue Shield of Louisiana Members

    Jun 1, 2023, 00:00
  • PCR191 A Review of the Influence of Stakeholder Preference Research on the EtR Framework

    Jun 1, 2023, 00:00
  • MSR88 Demonstrating the Generalizability of Claims Based Studies

    Jun 1, 2023, 00:00
  • CO57 Real-World Differences between People Living with HIV Receiving B/FTC/TAF and Those Receiving Other Single Tablet Regimens (STR) in the United States

    Jun 1, 2023, 00:00
  • HSD34 Screening for Colorectal Cancer in Childhood Cancer Survivors

    Jun 1, 2023, 00:00
  • HSD65 From the Triple Aim to the Quintuple Aim to the ISPOR Value Flower: Are Health Systems Prepared for High-Value Cell and Gene Therapies?

    Jun 1, 2023, 00:00
  • EE442 Direct Expenses Study of Liver Transplantation Treatment

    Jun 1, 2023, 00:00
  • CO120 Real-World Effectiveness of Monoclonal Antibodies for Patients with Multiple Myeloma: A Systematic Literature Review

    Jun 1, 2023, 00:00
  • Dynamic Simulation Modeling Methods for Health Economics

    Jun 1, 2023, 00:00
  • MSR83 Predicting Pseudo Individual Patient-Level Data with Covariates

    Jun 1, 2023, 00:00
  • EE400 Economic Impact of Clinical Pharmacist Interventions in the Neonatal Intensive Care Unit in Qatar

    Jun 1, 2023, 00:00
  • EE8 Cost-Effectiveness of Long-Term Medication Therapy for Obesity Management

    Jun 1, 2023, 00:00
  • EE422 Estimated Annual Costs for Hemophilia a Care in Brazil

    Jun 1, 2023, 00:00
  • EE255 Healthcare Costs of Patients with Amyotrophic Lateral Sclerosis with Commercial or Medicare Insurance

    Jun 1, 2023, 00:00
  • EE150 A Budget Impact Analysis of the Introduction of Mosunetuzumab for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in the United States (US)

    Jun 1, 2023, 00:00
  • RWD141 AI-Powered Pre-Competitive Disease and Care Modeling: Building a Reference Disease-Centric Framework for Value-Based Decision Making

    Jun 1, 2023, 00:00
  • EE552 Importance of Half Cycle Correction for Cost-Effectiveness Analysis: Case Study of Sacubitril/Valsartan Vs in Enalapril Heart Failure with Reduced Ejection Fraction

    Jun 1, 2023, 00:00
  • HSD101 The Key Role of Therapeutic Professionals in Rett Syndrome Care Pathway

    Jun 1, 2023, 00:00
  • EE508 Cost of Liver Cancer Screening in Patients with Cirrhosis

    Jun 1, 2023, 00:00
  • EE34 Cost-Effectiveness Analysis of Valbenazine Compared with Deutetrabenazine for the Management of Huntington Chorea

    Jun 1, 2023, 00:00
  • PCR71 Does Disease Impact Go Beyond the Healthcare System? Lessons from Generalized Myasthenia Gravis 360°

    Jun 1, 2023, 00:00
  • RWD46 Reclassification of COVID-19 Related ICD-10 Codes in Mexico: A Real-World Data Analysis of 1,937,360 Hospital Discharges from the Ministry of Health

    Jun 1, 2023, 00:00
  • EPH170 Diagnoses of Long COVID in the United States: Analysis of a Large Claims Database

    Jun 1, 2023, 00:00
  • HPR4 $20.9 Billion Annually Wasted on “Defects in Value” for Total Knee and Hip Replacements in the United States

    Jun 1, 2023, 00:00
  • HPR40 Price Analysis of New Nervous System Drugs Marketed in the US (1980-2021)

    Jun 1, 2023, 00:00
  • RWD33 Cardiac Implantable Electronic Device Centers’ Landscape in the Brazilian Public Healthcare: A 12-Year Real World Data Analysis

    Jun 1, 2023, 00:00
  • PCR54 A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Patient Reported Outcome Measures (PROMS): Part II Psychometric Properties

    Jun 1, 2023, 00:00
  • HPR118 Examining Non-Price Determinants of Regional Pharmaceutical Expenditures-a Case of Burkina Faso

    Jun 1, 2023, 00:00
  • EE545 Economic Burden in Patients with Hemophilia with Inhibitors: Results from a Real-World Cohort Study in the United States

    Jun 1, 2023, 00:00
  • HSD21 Telehealth: Interconnected Future of Healthcare in Emirate of Dubai, a Claims Data Analysis

    Jun 1, 2023, 00:00
  • EE542 The Burden of Disease of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Guatemala

    Jun 1, 2023, 00:00
  • EE329 The Value-Based Price for a Bivalent COVID-19 Booster Vaccine in the United Kingdom

    Jun 1, 2023, 00:00
  • EE466 Correcting a Cost-Effectiveness Analysis (CEA) with Suggestions on Ways of Avoiding Misinterpretations and Calculating Errors Associated with Them: The Singapore Diabetes Prevention (CEA)

    Jun 1, 2023, 00:00
  • CO108 Longitudinal Trends in Hospitalization Rates in Patients with Later-Onset Spinal Muscular Atrophy (SMA) Treated with Nusinersen up to 4.5 Years: Results from the Cherish and Shine Studies

    Jun 1, 2023, 00:00
  • EE100 Application of Real-World Data in Health Economic Evaluations in China: A Systematic Review

    Jun 1, 2023, 00:00
  • EPH192 Association of Long COVID with Seeing Difficulties Among Adults in the United States

    Jun 1, 2023, 00:00
  • EE402 Cost-Effectiveness Analysis of Pasireotide Long-Acting Release As a Second Line Treatment for Adult Acromegaly Patients

    Jun 1, 2023, 00:00
  • HTA55 Implications of EU HTA on Acceptance of Indirect Comparisons in National Assessments

    Jun 1, 2023, 00:00
  • EE517 The Potential Effect of Future Medical Cost Changes on the Net Cost of Multi-Cancer Early Detection Testing

    Jun 1, 2023, 00:00
  • RWD10 Risk of Depression before Alzheimer’s Disease Diagnosis and Hyperlipidemia Using Real-World Data

    Jun 1, 2023, 00:00
  • HPR100 Trends in FDA Approvals of Cardiovascular Drugs and Medical Devices (1980-2021)

    Jun 1, 2023, 00:00
  • CO225 An Evaluation of the Design of Clinical Trials Conducted for Rheumatoid Arthritis, 2009-2022

    Jun 1, 2023, 00:00
  • EE109 Cost Effectiveness of Dual Vs. Triple Therapy in Management of Atrial Fibrillation with Percutaneous Coronary Intervention

    Jun 1, 2023, 00:00
  • HTA20 Deconstructing ICER Value Assessments: Which Components Do Payers Value Most?

    Jun 1, 2023, 00:00
  • EE318 Trends in Prices of New Oral Drugs for Chronic Use Approved By the FDA (1980-2021)

    Jun 1, 2023, 00:00
  • CO196 Metformin Is Associated with Reduced Risk of Sepsis: Analysis of a U.S. Cohort from 2009-2019

    Jun 1, 2023, 00:00
  • EPH31 Incidence of Malignancies in Sickle Cell Disease: A Systematic Review

    Jun 1, 2023, 00:00
  • EE125 Economic Evaluations of Pharmacological Treatments for Active Tuberculosis: A Systematic Review

    Jun 1, 2023, 00:00
  • An Interview With the Food and Drug Administration About Draft Patient-Focused Drug Development Guidance 3: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments

    Jun 1, 2023, 00:00
  • HSD52 Closed Health Systems As Early Adopters and Incubators for Digital Behavioral Health Therapeutics

    Jun 1, 2023, 00:00
  • EPH191 Identifying Geographic Disparities in Access to Psoriasis Care in Medicaid Patients

    Jun 1, 2023, 00:00
  • P2 Economic Evaluation of Exagamglogene Autotemcel (EXA-CEL) Gene-Edited Therapy in Patients with Transfusion-Dependent Beta-Thalassemia

    Jun 1, 2023, 00:00
  • HSD26 Relationship between Sociodemographic Factors and Postpartum Depression Screening and Treatment

    Jun 1, 2023, 00:00
  • EPH245 Comparison of Intravitreal Fariciab and Aflibercept in the Treatment of Age-Related Macular Degeneration and Diabetic Macular Edema: A Meta-Analysis and Systematic Review

    Jun 1, 2023, 00:00
  • HPR27 Socioeconomic Inequalities in out of Pocket and Catastrophic Health Expenditures Among the Households in Pakistan

    Jun 1, 2023, 00:00
  • EPH130 Association of Lynch Syndrome with Skin Cancer: An Exploratory Analysis Using Claims Data

    Jun 1, 2023, 00:00
  • HPR24 Characteristics, Healthcare Resource Utilization, Cost, and Quality Outcomes of Medicare Beneficiaries While Commercially Insured and after Transition to Medicare Advantage Versus Traditional Fee-for-Service

    Jun 1, 2023, 00:00
  • EE440 Trends in the Cost of Total Knee Arthroplasty — a US Hospital Database Analysis, 2000–2021

    Jun 1, 2023, 00:00
  • RWD3 Group-Based Trajectory Modeling to Evaluate Adherence Patterns for Direct Oral Anticoagulant Among Patients with Atrial Fibrillation

    Jun 1, 2023, 00:00
  • PCR73 Health-Related Quality of Life and Economic Burden in Chinese Patients with Cutaneous T-Cell Lymphoma (CTCL) – Results from Interim Analysis

    Jun 1, 2023, 00:00
  • EE337 Per-Member Per-Month Expenditure Value in Non-Oncology: A Targeted Review and Opinion

    Jun 1, 2023, 00:00
  • MSR60 Merc: An R Package for Correcting Measurement Error Bias Based on Regression Calibration Method

    Jun 1, 2023, 00:00
  • MSR13 Identification of Longitudinal Trajectories of Medication Non-Adherence and Their Time-Varying Predictors in Aging Patients in the United States

    Jun 1, 2023, 00:00
  • PCR130 Beliefs Regarding Patient Experience in the Emergency Department Among Individuals Living with Sickle Cell Disease

    Jun 1, 2023, 00:00
  • CO138 Comparative Effectiveness and Costs of Sacubitril/Valsartan Versus Angiotensin Receptor Blockers in Heart Failure with Preserved Ejection Fraction

    Jun 1, 2023, 00:00
  • P38 Current Practices and Challenges When Submitting Patient Experience Data for US Regulatory Decision-Making: An Industry Survey

    Jun 1, 2023, 00:00
  • HSD91 Practice Patterns and Patient Management Techniques Utilizing Patient-Reported Outcomes Among Community Oncologists

    Jun 1, 2023, 00:00
  • PCR83 Defining the Smallest Worthwhile Effect of Treatment for Progressive Nervous System Tumors in People with NF2-Related Schwannomatosis: Qualitative Patient Interview Results from a Multicenter Clinical Trial

    Jun 1, 2023, 00:00
  • Organizational Practices

    Jun 1, 2023, 00:00
  • PCR151 Adherence to Direct Oral Anticoagulants and Incidence of Stroke/Acute Coronary Syndrome/Systemic Embolism Among Patients with Atrial Fibrillation Using a Marginal Structural Model

    Jun 1, 2023, 00:00
  • EE333 Assessment of Medically-Attended COVID-19 Patient Risk Profiles and Health Care Resource Utilization (HCRU) and Costs in the U.S.

    Jun 1, 2023, 00:00
  • EE115 Nash Progression Rates Based on Fibrosis and Inflammation (NAS): A Paired Biopsy Analysis from a Natural History Cohort in the US

    Jun 1, 2023, 00:00
  • PCR38 Contextualizing Health-State Utilities in Patients with Transfusion-Dependent eta-Thalassemia (TDT)

    Jun 1, 2023, 00:00
  • CO9 A Real-World Examination of HBA1C Reduction and Target Achievement Comparing SGLT2 Inhibitors and GLP1 Receptor Agonists As Second-Line Augmentation to Metformin for Treating Type II Diabetes

    Jun 1, 2023, 00:00
  • EE145 Real-World Healthcare Resource Use, Costs, and Treatment Patterns in Advanced or Metastatic Non-Small Cell Lung Cancer Patients with Different Epidermal Growth Factor Receptor Mutation Types

    Jun 1, 2023, 00:00
  • EE345 Strengths and Limitations of Different Costing Approaches Used for Hospital Budget Impact Models: Application to Imaging Guidance in Left Atrial Appendage Occlusion Procedures

    Jun 1, 2023, 00:00
  • EPH164 Atrial Fibrillation Is Associated with Higher Incidence of Frailty in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study

    Jun 1, 2023, 00:00
  • EE136 Cost-Effectiveness Analysis for Implants of Knee Replacement Surgery in the UK: Discrete-Time Cohort Markov Economic Model

    Jun 1, 2023, 00:00
  • SA9 A Comparison of All-Cause and Knee Osteoarthritis (KOA)-Related Costs of Newly-Diagnosed Koa Patients Treated with Multi-Injection IA-HAs: A Retrospective Database Analysis

    Jun 1, 2023, 00:00
  • EPH80 Predicting Anxiety and Depression in the First Year Following Breast Cancer Diagnosis Using a Large Administrative Claims Data

    Jun 1, 2023, 00:00
  • HPR41 Predictors of Epidermal Growth Factor (EGFR) Testing Among Patients with Metastatic Non-Small Cell Lung Cancer (MNSCLC) Treated in the Real-World Setting

    Jun 1, 2023, 00:00
  • HTA86 Establishing the Multi-Criteria Decision Analysis (MCDA) Framework to Assess the Value of Orphan Drugs in China: From the Perspective of Stakeholders and the Public

    Jun 1, 2023, 00:00
  • MSR109 When Can an Unanchored Analysis be More Credible Than an Anchored One?

    Jun 1, 2023, 00:00
  • EPH166 The Effect of COVID-19 on Maternal and Neonatal Outcomes in a Large Tertiary Health System in Saudi Arabia

    Jun 1, 2023, 00:00
  • EE309 The Economic Burden of B-Thalassaemia, Sickle Cell Disease, and Myelodysplastic Syndrome: A Literature Review

    Jun 1, 2023, 00:00
  • PCR46 Preferences for Attributes of Oral Antipsychotic Treatments: Survey Results of Patients Living with Schizophrenia or Bipolar I Disorder

    Jun 1, 2023, 00:00
  • RWD165 Inequities Related to Life Expectancy of Duchenne Muscular Dystrophy in Brazil: An Administrative Database Analysis

    Jun 1, 2023, 00:00
  • HPR112 Systematic Review for Rare Diseases Policy: A Sight in Peru and Colombia

    Jun 1, 2023, 00:00
  • EPH72 Prevalence of Fractures in People over 50 Years of Age with Osteoporosis in Colombia

    Jun 1, 2023, 00:00
  • HPR7 Racialized Economic Segregation and Inequities in Survival Among Patients with Multiple Myeloma

    Jun 1, 2023, 00:00
  • PCR240 Comprehension of the Urticaria Activity Score (UAS) Measure and Patient Guidance Document: Qualitative Interviews with Adults and Adolescents with Chronic Spontaneous Urticaria (CSU)

    Jun 1, 2023, 00:00
  • HPR15 Is Drug Novelty Associated with Greater Health Benefits?

    Jun 1, 2023, 00:00
  • EE154 Budget Impact Analysis of Pembrolizumab Plus Enfortumab Vedotin As First-Line Treatment of Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma in USA

    Jun 1, 2023, 00:00
  • EE354 Cost Benefit Associated with the Use of SITZMARKS® for the Diagnosis of Constipation in an Adult Population

    Jun 1, 2023, 00:00
  • PCR201 Digital Health Literacy of Parents and Health-Related Quality of Life of Their Children with Type 1 Diabetes Mellitus

    Jun 1, 2023, 00:00
  • EE78 Budget Impact Analysis of Proactive Therapeutic Drug Monitoring for Inflammatory Bowel Disease Patients in the United States on Infliximab Therapy

    Jun 1, 2023, 00:00
  • EE232 Impact of Updated Mortality Estimates on the Cost-Effectiveness of Rifaximin for the Treatment of Patients with Overt Hepatic Encephalopathy

    Jun 1, 2023, 00:00
  • HSD108 Adapting Evidence-Based Peri-Discharge Interventions for Reducing 30-Day Hospital Readmissions Among COPD Patients in Hong Kong: A Delphi Study Guided By the Grade Evidence-to-Decision Framework

    Jun 1, 2023, 00:00
  • PCR138 Multimorbidity and Chronic Pain Management with Opioids and Other Therapies Among Adults in the United States

    Jun 1, 2023, 00:00
  • CO107 Physical Therapy Versus Watchful Waiting for the Treatment of Adhesive Capsulitis of the Shoulder: A Prospective Randomized Controlled Trial

    Jun 1, 2023, 00:00
  • EPH149 Risk Factors of Delayed Methotrexate Elimination after Receiving High-Dose Methotrexate Therapy

    Jun 1, 2023, 00:00
  • PCR203 The Clinical and Financial Impact of GLP-1 Receptor Agonist and SGLT-2 Inhibitor Use in Type 2 Diabetes Management of Blue Cross and Blue Shield of Louisiana Members

    Jun 1, 2023, 00:00
  • HSD79 Trends of Genetic Testing Patterns, Survival, and Medical Costs of Individuals Newly Diagnosed with Metastatic Non-Small Cell Lung Cancer

    Jun 1, 2023, 00:00
  • HTA15 Beyond Value Assessment: Payer Perceptions of ICER’s Policy Initiatives

    Jun 1, 2023, 00:00
  • RWD160 Race-Stratified Treatment Patterns Among Metastatic Hormone Sensitive Prostate Cancer Patients in US Community Oncology Practice Setting

    Jun 1, 2023, 00:00
  • EPH66 Epidemiological Population Study of Sars-Cov-2 in Lake County, Illinois: Contact: Health-Related Quality of Life Assessment

    Jun 1, 2023, 00:00
  • PCR213 Fear of Progression in Multiple Sclerosis: Evaluation of Existing Patient-Reported Outcomes (PRO) Instruments

    Jun 1, 2023, 00:00
  • EPH4 Validation of Novel Identification Algorithms for Nonfatal Myocardial Infarction Using Uniform Objective Criteria and Pooled Clinical Trial Data

    Jun 1, 2023, 00:00
  • EE344 Cost-Effectiveness of a Novel Treatment for Stroke Prevention in Patients with Atrial Fibrillation: Results from an Early Economic Analysis

    Jun 1, 2023, 00:00
  • EE193 Burden of Severe Infections in Primary Immunodeficiency (PI) Diseases

    Jun 1, 2023, 00:00
  • MSR74 Comparison of Cure Versus Standard Parametric Models Using Advanced Melanoma Data

    Jun 1, 2023, 00:00
  • PCR62 Post-Lockdown Behaviors and Impacts of Avoiding COVID-19 in Individuals and Caregivers of Individuals at High-Risk of Severe COVID-19: A Qualitative Study

    Jun 1, 2023, 00:00
  • MT35 Prevalence of Medicare Beneficiaries Suitable for Transanal Irrigation Therapy Among Patients with Neurogenic Bowel Dysfunction

    Jun 1, 2023, 00:00
  • EE131 Post-Traumatic Stress Disorder (PTSD) in Caregivers: Review of the Existing Evidence and Proposed Framework to Estimate Economic Burden

    Jun 1, 2023, 00:00
  • EE319 Healthcare Resource Utilization and Direct Medical Costs Associated with Post COVID-19 Condition in Colombia, 2020-2021

    Jun 1, 2023, 00:00
  • EPH226 Medical Cost and Prevalence of Mental Diseases across Different Health Insurance Systems in Japan

    Jun 1, 2023, 00:00
  • HSD85 The Impact of a Virtual Home Environmental Assessment and Modification Project on Pediatric Asthma Symptom Burden and Control

    Jun 1, 2023, 00:00
  • HSD10 Efficiency of the Cervical Cancer Program on the Budget Execution Processes during COVID 19 Pandemic Years 2020 - 2021 in Peru

    Jun 1, 2023, 00:00
  • EPH23 Disease Modifying Therapy (DMT) Utilization and Health Care Resource Utilization (HCRU) Among Adults with Multiple Sclerosis (MS) in a United States-Based Real-World Cohort

    Jun 1, 2023, 00:00
  • EPH13 Trends in Mortality Related to Hepatitis C in Colombia 1997 – 2020

    Jun 1, 2023, 00:00
  • EPH40 A Retrospective Cohort Study of Veteran′s Affairs Data: Epidemiology, Treatments, Clinical Outcomes, and Burden of Immunoglobulin a Nephropathy

    Jun 1, 2023, 00:00
  • SA37 Real-World Treatment Patterns (TxP) and Healthcare Resource Utilization (HRU) in Patients with Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) and Metastatic Hormone-SensitiveProstate Cancer (mHSPC) in China

    Jun 1, 2023, 00:00
  • HTA61 Do NICE Technology Appraisals Account for Unmet Medical Need in Oncology?

    Jun 1, 2023, 00:00
  • PCR75 Assessment of Completion Time to Optimize the Administration of Common Patient-Reported Outcome Measures (PROMS) in Oncology Clinical Trials

    Jun 1, 2023, 00:00
  • EPH169 Persons Diagnosed with COVID-19 in Linked Clinical Practice Research Datalink (CPRD) – Hospital Episode Statistics (HES) Data: A Cohort Description

    Jun 1, 2023, 00:00
  • RWD2 A Retrospective Cohort Study of Patients with Venous Thromboembolism (VTE): An Analysis from a Healthcare Maintenance Organization (HMO) Perspective in Brazil

    Jun 1, 2023, 00:00
  • HSD29 Predictors of Neurokinin-Receptor Antagonist (NK1-RA) Overuse Among Women with Breast Cancer

    Jun 1, 2023, 00:00
  • EE498 Economic Evaluation of Nanoparticle Albumin-Bound paclitaxel for Previously Treated Advanced NSCLC in Japan

    Jun 1, 2023, 00:00
  • RWD162 An Overview of Real-World Data Sources for Real-World Studies in Oncology and Rare Diseases in China

    Jun 1, 2023, 00:00
  • HPR128 Use of Clinical Outcomes Assessments (COAS) By Hospitals in the USA, UK, France and Sweden: Multi-Stakeholder Viewpoints

    Jun 1, 2023, 00:00
  • CO182 Developing Methods to Validate Outcome Measures Captured Via Wearable Activity Trackers

    Jun 1, 2023, 00:00
  • CO22 Tools for Assessing Therapeutic Progress in Patients with Rett Syndrome

    Jun 1, 2023, 00:00
  • MSR37 Identifying Clinical Subtypes of Long COVID: An Unsupervised Machine Learning Approach

    Jun 1, 2023, 00:00
  • CO64 Efficacy and Safety of Exenatide for the Treatment of Parkinson’s Disease: A Systematic Literature Review

    Jun 1, 2023, 00:00
  • EE209 Value Defects in Spine Surgery: How to Reduce Wasteful Care and Improve Value

    Jun 1, 2023, 00:00
  • PCR210 Adaptive Choice Based Conjoint Contribution to the Elicitation of Patients’ Preferences and Shared Decision-Making Process for the Pharmaceutical Treatment for Osteoarthritis

    Jun 1, 2023, 00:00
  • PCR177 Characterizing Patient Burden in Leber’s Hereditary Optic Neuropathy Using Mixed Methods Research

    Jun 1, 2023, 00:00
  • PCR94 Uncovering Patient-Reported Outcome Differences between Undiagnosed and Diagnosed Individuals with Moderate to Severe Psoriasis

    Jun 1, 2023, 00:00
  • CO121 Using Stated-Preferences Methods to Develop a Summary Metric to Determine Successful Treatment of Children with a Surgical Condition to Compare across Hospitals

    Jun 1, 2023, 00:00
  • EE3 Cost Estimation of Published Heart Failure and Edema Events in Hyperkalemic Patients on Patiromer and Sodium Zirconium Cyclosilicate

    Jun 1, 2023, 00:00
  • EE173 Economic Evaluation of Exagamglogene Autotemcel (EXA-CEL) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises

    Jun 1, 2023, 00:00
  • EPH59 Validating Claims-Based Identification of Patients with Overweight and Obesity Using a Linked Claims-Electronic Medical Record Database

    Jun 1, 2023, 00:00
  • EE371 Trends in the Economic Burden of Rheumatoid Arthritis in the US, 2008-2019

    Jun 1, 2023, 00:00
  • RWD79 Relationship between Body Mass Index and Diagnosis of Overweight or Obesity in Veteran’s Administration Population

    Jun 1, 2023, 00:00
  • PCR242 Impacts of Financial Incentives on the Uptake of Influenza Vaccination Among the Elderly: Results from a Pragmatic Randomized Controlled Trial in Beijing

    Jun 1, 2023, 00:00
  • EPH231 Cardiovascular Burden of Patients Diagnosed with Idiopathic Hypersomnia: Real-World Idiopathic Hypersomnia Total Health Model (CV-RHYTHM)

    Jun 1, 2023, 00:00
  • EE410 The Insurance Payer Perspective on Management Options for Early Pregnancy Loss in the United States

    Jun 1, 2023, 00:00
  • PCR114 Utilizing Time-Driven Activity Based Costing to Explore Variation in the Value of Hip Arthroscopy for Acetabular Labral Repair

    Jun 1, 2023, 00:00
  • RWD5 Uniting Claims and Electronic Health Records Data to Build a Predictive Model for Need of Palliative Care in Chronic Disease Patients in the US

    Jun 1, 2023, 00:00
  • MSR15 Psychometric Validation of the Electronic Hidradenitis Suppurativa (HS) Symptom Daily Diary (eHSSDD) and Electronic HS Symptom Questionnaire (eHSSQ) Using Data from the Phase 3 BE HEARD Trials of Bimekizumab in HS

    Jun 1, 2023, 00:00
  • EE472 US Cost-Effectiveness of Lenacapavir Plus Optimized Background Regimen Versus Other Treatments for Multi-Drug Resistant HIV

    Jun 1, 2023, 00:00
  • EE384 Cost-Effectiveness of Hemithyroidectomy Versus Total Thyroidectomy for Patients with Low Risk Differentiated Thyroid Cancer

    Jun 1, 2023, 00:00
  • EE124 Cost-Effectiveness Analysis of Dolutegravir/Lamivudine (DTG/3TC) Versus Elvitegravir/Cobicistat/Tenofovir Alafenamide/Emtricitabine (EVG/C/TAF/FTC) for HIV-1 Infection Management in Treatment-Experienced Patients in China

    Jun 1, 2023, 00:00
  • EE245 Years of Potential Productive Life Lost Mortality Caused By Injury in Mongolia

    Jun 1, 2023, 00:00
  • EPH157 Environmental Pollution and Socioeconomic Status in Eastern China

    Jun 1, 2023, 00:00
  • CO66 Real-World Study on Characteristics, Post-Nephrectomy Journey, and Outcomes of Patients with Early-Stage Renal Cell Carcinoma Based on Risk Groups

    Jun 1, 2023, 00:00
  • CO29 Post Distant Recurrence (DR) Survival of Muscle-Invasive Urothelial Carcinoma (MIUC) Patients with Prior Radical Cystectomy (RC): Analysis of a Flatiron Real-World Cohort Matched to CheckMate-274

    Jun 1, 2023, 00:00
  • EE527 A Systematic Literature Review of the Economic Burden of Leber Hereditary Optic Neuropathy (LHON)

    Jun 1, 2023, 00:00
  • EE143 Cost-Effectiveness of Ocrelizumab in First-Line Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis in Chile

    Jun 1, 2023, 00:00
  • EE387 Cost of Non-Melanoma Skin Cancer Care in the U.S.- An Analysis from Medicare Population

    Jun 1, 2023, 00:00
  • CO177 The Burden of Spinal Muscular Atrophy Type 1 on Caregivers in Argentina: First Results of a Global Survey Launched in Latin America

    Jun 1, 2023, 00:00
  • EE390 Healthcare Resource Utilization (HCRU) and Costs in Patients with Metastatic Urothelial Cancer (MUC) Who Received First-Line (1L) Treatment: Results from Impact UC II

    Jun 1, 2023, 00:00
  • EPH155 Relative Effectiveness of Vaccination and Non-Pharmaceutical Interventions on COVID-19 Infection and Deaths in the US

    Jun 1, 2023, 00:00
  • PCR21 Patient-Reported Outcomes to Support Regulation, Reimbursement and Health Policy Among Patients with Head and Neck Cancers: A Systematic Review

    Jun 1, 2023, 00:00
  • P27 The Impact of Incorporating Survival Heterogeneity into Modeling of Survival Outcomes for Patients with Muscle-Invasive Bladder Cancer after Radical Resection: Analyses from a Retrospective Real-World Study in France

    Jun 1, 2023, 00:00
  • HPR50 Exploring the Contribution of Health Gains and Cost-Offsets to Value-Based Drug Prices in Prior ICER Reviews

    Jun 1, 2023, 00:00
  • HSD51 Differences in Disease Burden and Treatment Utilization By Socioeconomic Status Among a Large Cohort of Patients with COVID-19 Diagnosis in the United States

    Jun 1, 2023, 00:00
  • PCR230 Estimating Utility Values Using the Duchenne Muscular Dystrophy-Quality of Life Measure (DMD-QOL): A New Preference-Based Measure for Duchenne Muscular Dystrophy

    Jun 1, 2023, 00:00
  • EPH209 Descriptive Analysis of High-Cost Claimants in a Multi-Employer Database

    Jun 1, 2023, 00:00
  • HPR139 Impact of Price Negotiation on the Pricing of Anticancer Drugs in China

    Jun 1, 2023, 00:00
  • EPH215 Yearly Trend of Obesity Prevalence Among Hospitalized Patients in the United States: 2017−2021

    Jun 1, 2023, 00:00
  • HPR39 A Time-to-Event Framework for Quantifying Clinical Significance of Effect in Alzheimer’s Disease Clinical Trials

    Jun 1, 2023, 00:00
  • RWD176 Use of the Narcotics Information Management System (NIMS) Data for Regulatory Scien Focusing on Methylphenidate Prescription

    Jun 1, 2023, 00:00
  • HSD19 Comparing the Health Care Utilization of Those with Limited English Proficiency and Use of a Language Interpreter to Similar Individuals without Use of a Language Interpreter at Mayo Clinic

    Jun 1, 2023, 00:00
  • EE346 Opportunity Cost of Not Preventing Heart Failure: Case Study of a Public Hospital in Ecuador

    Jun 1, 2023, 00:00
  • CO46 Determining Patient-Reported Outcomes Fit-for-Purpose By Cross-Linking Regulatory Perspective and Descriptive Information in Interconnected Databases

    Jun 1, 2023, 00:00
  • EPH98 Cutaneous Adverse Drug Reactions of COVID-19 Vaccines: A Cross-Sectional Study of the Largest Healthcare System in Taiwan

    Jun 1, 2023, 00:00
  • CO181 Clinical Characteristics of Patients with Sars-Cov-2 Omicron Variant and COVID-19 Vaccination with Clinical Outcome Findings in Shanghai, China: A Single Center, Retrospective, Observational Study

    Jun 1, 2023, 00:00
  • EE281 Trends in Approvals and Price at Market Entry of New Drugs for Breast Cancer in the US (1980-2022)

    Jun 1, 2023, 00:00
  • SA41 Evolving Payer Perception on Patient Centricity and Real-World Eviden Insights from a Quantitative Survey

    Jun 1, 2023, 00:00
  • CO97 Risk Factors, Presentation and Outcome in Acute Ischemic Stroke According to Social Position Indicators in Patients Hospitalized in a Referral Center in Bogotá 2011-2019

    Jun 1, 2023, 00:00
  • EE105 Impact of Clinical Pharmacist Interventions on Economic Outcomes in Women's Wellness and Research Center in Qatar

    Jun 1, 2023, 00:00
  • EE135 Cost Comparison of a Smartphone-Based Care Platform Versus Traditional Care in Total Knee Arthroplasty in the US: An Integrated Healthcare Delivery System Perspective

    Jun 1, 2023, 00:00
  • MSR4 Rasch Calibration of the 18-Item Multidimensional Health Locus of Control - Form B Scale

    Jun 1, 2023, 00:00
  • EE448 The Burden of Illness for Metastatic Synovial Sarcoma (MSS) and Myxoid Round Cell Liposarcoma (MMRCLS): A Seer-Medicare Analysis

    Jun 1, 2023, 00:00
  • EE84 Cost-Effectiveness of Pembrolizumab Plus Nab-paclitaxel in Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (TNBC) Whose Tumors Expressed Pd-L1 (CPS ≥10) in Colombia

    Jun 1, 2023, 00:00
  • EE485 Healthcare Utilization and Costs Decreased Over Time with Nusinersen Treatment in Patients with Spinal Muscular Atrophy

    Jun 1, 2023, 00:00
  • PCR115 Adherence to Disease-Modifying Treatments in Patients with Active and Nonactive Progressive Multiple Sclerosis in the United States

    Jun 1, 2023, 00:00
  • EE146 Cost-effectiveness of Tepotinib for Patients With Previously Treated Advanced Non-Small Cell Lung Cancer Harboring Metex14 Skipping Alterations in Spain

    Jun 1, 2023, 00:00
  • MT12 Evaluation of Digital Mental Health Therapeutics in the United States: A Systematic Literature Review and Mixed-Methods Framework Synthesis

    Jun 1, 2023, 00:00
  • SA59 Literature Review of Statistical Methods Comparisons through Simulations When Using External Control Arm for Regulatory or HTA Submissions

    Jun 1, 2023, 00:00
  • EPH160 Racial/Ethnic Differences in the Use of Angiotensin II Receptor Stimulatory Vs. Inhibitory Antihypertensive Among US Adults with Hypertension

    Jun 1, 2023, 00:00
  • RWD171 Disparity in Disease Severity and Treatment Utilization for Atopic Dermatitis (AD) Patients in the US

    Jun 1, 2023, 00:00
  • EPH3 Comparing Cardiac Safety Profile of Metformin and Sulfonylureas in Colorectal Cancer (CRC) Patients with Type 2 Diabetes Mellitus (T2DM): Surveillance, Epidemiology and End Results (SEER) Medicare Analysis

    Jun 1, 2023, 00:00
  • HSD16 Impact of Provider Nudges on Herpes Zoster Vaccine Series Completion during the COVID-19 Pandemic in the United States

    Jun 1, 2023, 00:00
  • HSD99 Telemedicine and the Utilization of Outpatient Mental Health Services By Patients with Incident Major Depressive Disorder during the COVID-19 Pandemic

    Jun 1, 2023, 00:00
  • CO41 Real-World Outcomes of Nusinersen or Onasemnogene Abeparvovec (OA) Monotherapy, or Switching to OA from Nusinersen in SMA Patients Aged ≥6 Months

    Jun 1, 2023, 00:00
  • HSD61 Patient Characteristics, Treatment Patterns, and Outcomes Among Early Tezepelumab Users: An Early View Claims Data Study

    Jun 1, 2023, 00:00
  • HPR152 Continuous Wound Infiltration: A Post-Surgical Pain Relief Solution That Reduces Opioid Use but Causes Pain in the Patient’s Wallet Due to Lack of Insurance Reimbursement

    Jun 1, 2023, 00:00
  • EE196 Impact of Inclusion of Finerenone in the Burden of Disease of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Ecuador

    Jun 1, 2023, 00:00
  • CO94 Status of Outcome-Based Contracts Amongst US Payers

    Jun 1, 2023, 00:00
  • HTA71 Transition Probabilities in State-Transition Models: A Synopsis of HTA Guidelines Worldwide

    Jun 1, 2023, 00:00
  • CO171 Mental Health and Sleep Disorders in Pediatric Patients with and without Atopic Dermatitis

    Jun 1, 2023, 00:00
  • EE518 Characteristics of the Clinical Pharmacist Interventions at a Tertiary Cancer Care Hospital in Qatar

    Jun 1, 2023, 00:00
  • RWD84 A Comparison of Oral Aripiprazole with an Ingestible Sensor with Oral Atypical Antipsychotic Treatment and Impact on Psychiatric Hospitalizations in Adults with Schizophrenia in a Real-World Care Setting

    Jun 1, 2023, 00:00
  • PCR222 The Value of No Cancer Signal Detected Results from Multi-Cancer Early Detection Tests–Perspectives of People in the General Population

    Jun 1, 2023, 00:00
  • RWD153 Investigating Trends of Behavioral Healthcare Resource Utilization Burden in Children and Adolescents with Suicidal Symptoms in the United States: An Analysis of Electronic Health Record Data

    Jun 1, 2023, 00:00
  • CO159 Treatment Characteristics of Adults with Hepatocellular Carcinoma after Curative Resection or Ablation: A Multinational, Retrospective Chart Review Study

    Jun 1, 2023, 00:00
  • HTA27 A Pipeline Analysis of Immuno-Oncology Medicines - Pembrolizumab, Nivolumab, and Atezolizumab

    Jun 1, 2023, 00:00
  • CO40 Impact of Long-Acting Modality on Health Technology Assessments and Formulary Decision Making in the EU4 and USA

    Jun 1, 2023, 00:00
  • EPH108 Relationships between Zip Code Level Social Determinants of Health and Type 2 Diabetes Medication Adherence

    Jun 1, 2023, 00:00
  • RWD181 Healthcare Resource Utilization and Economic Burden of Hidradenitis Suppurativa in the USA Using Marketscan Claims Data

    Jun 1, 2023, 00:00
  • CO69 Patient Journey of Triple Negative Breast Cancer in Five Healthcare Institutions from Colombia

    Jun 1, 2023, 00:00
  • CO152 Risk Factors Associated with Long Bone Fracture Non-Union – A US Claims Database Analysis

    Jun 1, 2023, 00:00
  • P4 Cost–Effectiveness Analysis of Ivosidenib Versus Chemotherapy for Previously Treated IDH1–Mutant Advanced Intrahepatic Cholangiocarcinoma in Taiwan

    Jun 1, 2023, 00:00
  • PCR86 Using Qualitative Methods to Develop Grounded Relevant Content for Preference Surveys in a Specific Rare Bleeding Disorder (SRBD)

    Jun 1, 2023, 00:00
  • PCR63 A Time Trade-Off Study to Estimate Respiratory Syncytial Virus (RSV) Related Utility Values for Older Adults (OA) in the United States (US)

    Jun 1, 2023, 00:00
  • RWD155 Lumateperone Persistency for the Treatment of Schizophrenia

    Jun 1, 2023, 00:00
  • SA60 Technology and Device Acceptance Among an Older Population for Decentralized Clinical Trial Participation

    Jun 1, 2023, 00:00
  • SA51 Severity Diagnosis and Neuropsychological Test Result from Clinical Notes Among Veterans with Alzheimer's Disease

    Jun 1, 2023, 00:00
  • HSD63 Real-World Data Analysis of Genetic Testing for Inherited Retinal Diseases

    Jun 1, 2023, 00:00
  • EPH44 On the Frontline Against COVID-19: Provision of Community Pharmacy Services during a Public Health Crises

    Jun 1, 2023, 00:00
  • EPH46 The Association between Vaccine Hesitancy and Pertussis: A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00
  • P15 Indirect Treatment Comparisons of Time-to-Event Outcomes with Mis-Matched "Time Zero": Methodology and Application in Resectable Non-Small Cell Lung Cancer

    Jun 1, 2023, 00:00
  • CO114 Real-World Experience Among Patients with Mantle Cell Lymphoma after Covalent Bruton Tyrosine Kinase Inhibitor Use in the United States: A Retrospective Electronic Health Record-Derived Study

    Jun 1, 2023, 00:00
  • EE53 Cost-Minimization and Budget Impact Analysis of Venetoclax Versus Acalabrutinib for 1L and R/R Chronic Lymphocytic Leukemia in the Brazilian Public Healthcare System

    Jun 1, 2023, 00:00
  • RWD39 Who Is Using Data from the French Health Data Hub?

    Jun 1, 2023, 00:00
  • HSD35 If Primary Prevention Is the Solution, Why Don't We Take Advantage of All Opportunities in Brazil?

    Jun 1, 2023, 00:00
  • HSD80 How Are We Treating Our Patients? An Experts’ Panel Perspective from Brazilian Healthcare System on Treatment Access for Chronic Phase Chronic Myeloid Leukemia (CP-CML)

    Jun 1, 2023, 00:00
  • PCR167 Patient Preferences for Lung Cancer Interception Therapy

    Jun 1, 2023, 00:00
  • EPH185 Clinical, Humanistic, and Economic Benefits of Early Cancer Diagnosis: A Systematic Literature Review

    Jun 1, 2023, 00:00
  • HTA93 A Systematic Literature Review on Incorporating Equity Considerations in Health Technology Assessment (HTA)

    Jun 1, 2023, 00:00
  • EPH68 Impact of Treatment with Central Nervous System Stimulant and Risk of Substance Use Disorder in Adults with Attention-Deficit/Hyperactivity Disorder in West Virginia

    Jun 1, 2023, 00:00
  • Economic Considerations of Digital Health Technologies

    Jun 1, 2023, 00:00
  • RWD125 An Exploratory Analysis of Real-World Data for Assessing Patient Characteristics, Region, Stage, and PD-L1 Health-Care Utilization Among U.S. Patients with Advanced Lung Cancer

    Jun 1, 2023, 00:00
  • EE357 Implementing the Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Approach – A Case Example in HCV Therapies

    Jun 1, 2023, 00:00
  • Financing and Reimbursement of Approved Advanced Therapies in Several European Countries

    Jun 1, 2023, 00:00
  • CO65 Machine Learning-Based Explanation of Racial-Ethnic Disparities in 5-Year Cancer-Specific Survival Among Hormone Receptor-Positive Breast Cancer Patients in the United States

    Jun 1, 2023, 00:00
  • HSD49 Medication Use Among T2DM Patients Initiating Treatment with Once Weekly (OW) Semaglutide

    Jun 1, 2023, 00:00
  • EPH75 Risk Factors Associated with Newly Diagnosed Attention-Deficit/Hyperactivity Disorder in Adults

    Jun 1, 2023, 00:00
  • EE57 Healthcare Costs Avoided in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura with Caplacizumab in Colombia

    Jun 1, 2023, 00:00
  • EPH148 Burden of Opioid Use Disorder on Hospitals in the United States

    Jun 1, 2023, 00:00
  • P12 Unsupervised Clustering and Binary Classification Analysis for Predicting COVID Syndrome (LONG COVID) in US Adults

    Jun 1, 2023, 00:00
  • EPH201 Trends in Racial Disparities for Total Knee Arthroplasty — A US Hospital Database Analysis, 2000–2021

    Jun 1, 2023, 00:00
  • PCR126 Including Patient Relevant Endpoints (QUALITY OF LIFE) in Multicomponent Endpoints with Generalized Pairwise Comparisons

    Jun 1, 2023, 00:00
  • EPH246 Real-World Evaluation of Health Disparities in Treatment Patterns for Systemic Lupus Erythematosus

    Jun 1, 2023, 00:00
  • HPR44 Evolving PICO Characteristics in the Early Oncology Treatment Lifecycle: Differences from Trials to Treatment Guidelines

    Jun 1, 2023, 00:00
  • CO33 Early Hemoglobin and Quality-of-Life Trends from OPERA: A Real-World Study of Pegcetacoplan Treatment in US Adults with Paroxysmal Nocturnal Hemoglobinuria

    Jun 1, 2023, 00:00
  • HSD104 The Utilization of Antineoplastic Agents and Cost Analysis for Chinese Patients with Lung Cancer: A Retrospective Hospital Database Study

    Jun 1, 2023, 00:00
  • EE349 A Systematic Literature Review, Network Meta-Analysis, and Cost-Effectiveness Analysis of Resmetirom for the Treatment of Nonalcoholic Steatohepatitis

    Jun 1, 2023, 00:00
  • EE273 Cost-Effectiveness Analysis of First Line Treatment Strategies for Acute Promyelocytic Leukemia in Adults in Colombia

    Jun 1, 2023, 00:00
  • EE66 Estimating the Costs of Familial Hypercholesterolemia Management Using Primary Claims Data

    Jun 1, 2023, 00:00
  • EE389 Budget Impact of a Blood-Based Auto-Antibody Test to Up-Classify Risk of Pulmonary Nodules in a US Medicare Payer Setting

    Jun 1, 2023, 00:00
  • HSD109 Diabetic Retinopathy Patients at Initiation of Anti-Vascular Endothelial Growth Factor Injection

    Jun 1, 2023, 00:00
  • HPR153 Changing Vaccine Assessment Criteria and Focus Towards Prevention Strategies

    Jun 1, 2023, 00:00
  • EE121 Marginal Health Care Expenditure of Patients with Viral Hepatitis in the US: Analysis of Medical Expenditure Panel Survey 2011-2020

    Jun 1, 2023, 00:00
  • PCR143 Regulatory Recommendations for Patient Experience Data in North America, Europe, and Asia Pacific

    Jun 1, 2023, 00:00
  • HPR132 Pricing Variations between Early Access Prices and List Prices in Switzerland

    Jun 1, 2023, 00:00
  • CO140 Usual Care and Team-Based Care Vs. Trial Protocols for Hypertension Management in Sprint-Eligible US Adults: A Simulation Study

    Jun 1, 2023, 00:00
  • HSD98 Which Telehealth Features Matter Most? Ranking Results from HIV Care Providers and Patients Living with HIV in South Carolina

    Jun 1, 2023, 00:00
  • EPH168 Regional Variation in Patient Characteristics and Treatment Patterns for over 17 Million COVID-19 Patients in the United States

    Jun 1, 2023, 00:00
  • EPH176 What Macro-Level Social Determinants Are Associated with Mental Health Outcomes in Disability-Adjusted Life Year (DALY) for the Population Living in the Organisations for Economic Co-Operation and Development (OECD) Nations?

    Jun 1, 2023, 00:00
  • SA50 Comparative Efficacy of Bimekizumab in Biologic/Targeted Synthetic DMARD-Naïve Patients with Axial Spondyloarthritis: Results from a Systematic Literature Review and Network Meta-Analysis

    Jun 1, 2023, 00:00
  • HPR73 Time to Approval of Chimeric Antigen Receptor-T Cells (CAR-T) Therapies Among Nordic Countries

    Jun 1, 2023, 00:00
  • RWD159 Evolution of Cancer Treatment Cost in the Last 36 Months: An Analysis from a Health Payer Perspective in Brazil

    Jun 1, 2023, 00:00
  • HTA3 Analysis of Canadian and International Health Technology Assessment Uncertainty for Spinal Muscular Atrophy Therapies

    Jun 1, 2023, 00:00
  • EPH127 Understanding the Burden of Aromatic L-Amino Acid Decarboxylase Deficiency (AADCD): Results from a Clinician Expert Survey

    Jun 1, 2023, 00:00
  • PCR60 Oxford Participation and Activities Questionnaire (OX-PAQ): Tests of Data Quality, Score Reliability, Response Rate and Scaling Assumptions in People Aged 75 or over in Sweden

    Jun 1, 2023, 00:00
  • EE474 Clinical and Economic Burden of Invasive Escherichia coli Disease Among Medicare-Insured Patients

    Jun 1, 2023, 00:00
  • EE334 Characterizing When Health Equity Should be Considered in Economic Evaluations: A Systematic Review of Extended and Distributional Cost-Effectiveness Analyses

    Jun 1, 2023, 00:00
  • SA73 Use of Novel Qualitative Research Methods for Evidence Generation

    Jun 1, 2023, 00:00
  • RWD35 Coding Trends of Single Gene and Next Generation Sequencing Tests for Patients with Advanced Non-Small Cell Lung Cancer Using a EHR-Linked Claims Database

    Jun 1, 2023, 00:00
  • EPH61 Uptake of the Post COVID-19 Condition ICD-10-CM Diagnosis Code By Social Factors

    Jun 1, 2023, 00:00
  • CO202 Effect of an Oral, Fixed-Dose Combination of Sodium Phenylbutyrate and Taurursodiol on Long-Term Tracheostomy/Ventilation-Free Survival and Hospitalization in Amyotrophic Lateral Sclerosis: Final Results from Centaur

    Jun 1, 2023, 00:00
  • PCR207 Paired - Patient Reported Experiences and Perceived Benefit of Treatment with Dolutegravir/Lamivudine: Interim Analysis (N =100)

    Jun 1, 2023, 00:00
  • CO102 Impact of Quality Improvement Support Program for Korean Long-Term Care Hospitals on Nursing Outcomes

    Jun 1, 2023, 00:00
  • PCR27 Parents' Preference and Perception for Childhood Obesity Prevention Strategies in China: A Survey-Based Experiment

    Jun 1, 2023, 00:00
  • HSD20 The Changes of Prescription Patterns after Providing Therapeutic Duplication Dur(DRUG UTILIZATION REVIEW) Information in Outpatient Veterans at Vhs Medical Center

    Jun 1, 2023, 00:00
  • EE284 Exploring the Value of a Novel Health Technology Tool to Support Diagnosis of Autism Spectrum Disorder

    Jun 1, 2023, 00:00
  • Grading Evidence to Support Legislative and Budget Proposals—Veterans Health Administration’s Key to Implementing the Evidence Act

    Jun 1, 2023, 00:00
  • EPH219 Digital Contact Tracing for COVID-19: Overview of Existing Systems and Framework for Future Innovation

    Jun 1, 2023, 00:00
  • HTA34 A Review of Real-World Evidence in Health Technology Assessment Decision-Making of Gene Therapies in the US, Canada, UK, EU4, and Japan

    Jun 1, 2023, 00:00
  • HSD119 Influence of HEOR Evidence to Challenge the Status Quo for Training General Practitioners: A Case Study from Argentina

    Jun 1, 2023, 00:00
  • HPR33 Impact of Inflation Reduction Act (IRA) on Commercial Plans’ Approach to Managing Drugs

    Jun 1, 2023, 00:00
  • OP14 Just What the Doctor Ordered? A Review of Clinician Exposure to Health Economics and Outcomes Research

    Jun 1, 2023, 00:00
  • EPH161 Dose Escalation Patterns in Patients with Overweight or Obesity Initiating Semaglutide 2.4mg: A 6-Month Follow-up in a Real-World Setting in the United States

    Jun 1, 2023, 00:00
  • P6 Ethno-Racial Disparity Among Elderly Patients with Alzheimer’S Disease in the US Population: A Real World Study Based on Administrative Claims and Electronic Health Records Data

    Jun 1, 2023, 00:00
  • EPH30 Burden of HPV-Associated Cancers Among Men in Ecuador, 2015-2019

    Jun 1, 2023, 00:00
  • HSD25 Study of Pharmacists' Awareness Regarding Coronavirus Disease (COVID-19) in Ukraine

    Jun 1, 2023, 00:00
  • PCR199 Benefit-Risk Preferences of Patients for the Use of Artificial Intelligence and Ultrasound Imaging in Different Settings in Echocardiography

    Jun 1, 2023, 00:00
  • EE554 Budget Impact Analysis of Intravenous Acetaminophen in Neonates after Esophageal Atresia and Tracheoesophageal Fistula Repair

    Jun 1, 2023, 00:00
  • EE468 The Cost-Effectiveness and Budget Impact of Itopride Hydrochloride for the Treatment of Functional Dyspepsia in Vietnam

    Jun 1, 2023, 00:00
  • CO77 Relationships between Heterotopic Ossification Volume and Functional and Quality of Life Endpoints in Fibrodysplasia Ossificans Progressiva (FOP)

    Jun 1, 2023, 00:00
  • EE491 Informal Caregiver Time and Associated Cost in Patients with Alzheimer’S Disease in the United States (US): A Systematic Literature Review

    Jun 1, 2023, 00:00
  • EE523 Analysis of Healthcare Resource Utilization and Costs in Patients with Glycogen Storage Disease Type Ia (GSDIA)

    Jun 1, 2023, 00:00
  • EE116 Predicting High-Cost Diabetes Patients: An Analysis of Commercially-Insured Population

    Jun 1, 2023, 00:00
  • PCR209 Comparing the Value of Daily Measurement of Wellbeing for Individuals with Alcohol Use Disorder Versus Reimbursement-Based Timing

    Jun 1, 2023, 00:00
  • Indirect Treatment Comparisons of Lenacapavir Plus Optimized Background Regimen Versus Other Treatments for Multidrug-Resistant Human Immunodeficiency Virus

    Jun 1, 2023, 00:00
  • EE459 Racial Health Disparities in Acute Ischemic Stroke: A Targeted Literature Review for Estimates to be Used in Distributional Cost-Effectiveness Analysis

    Jun 1, 2023, 00:00
  • EE399 Assessing the Risks and Benefits Associated with Automation during Cell Expansion Processes at Cell and Gene Therapy Manufacturers

    Jun 1, 2023, 00:00
  • EE226 Cost-Effectiveness Analysis of Fixed-Dose Triple Combination Therapy (LINAGLIPTIN/METFORMIN/EMPAGLIFOZIN) Vs. Its Fixed-Dose Double Combination and Individual Components

    Jun 1, 2023, 00:00
  • EE280 Real-World Healthcare Resource Utilization of Patients with Metastatic Breast Cancer: A Retrospective Cohort Analysis

    Jun 1, 2023, 00:00
  • PCR28 Characterization of Patients with Duchenne Muscular Dystrophy across Previously Developed Health States

    Jun 1, 2023, 00:00
  • RWD136 Real-World Use of Biologic Disease-Modifying Anti-Rheumatic Drugs in US Patients with Ankylosing Spondylitis: Persistence, Factors Associated with Discontinuation, and Dosing Patterns

    Jun 1, 2023, 00:00
  • EPH116 Epidemiological and Economic Impact of a Rapid Antiretroviral Therapy Initiation in Newly Diagnosed People Living with HIV, from the Colombian’s Health System Perspective

    Jun 1, 2023, 00:00
  • CO127 Atopic March and Comorbidities in Patients with Atopic Dermatitis in Colombia

    Jun 1, 2023, 00:00
  • PCR178 Economic and Humanistic Burden of Neurofibromatosis Type 1 in China

    Jun 1, 2023, 00:00
  • EE533 Resource Use and Costs Among Hospital Births with Abnormal Postpartum Uterine Bleeding or Hemorrhage in the United States

    Jun 1, 2023, 00:00
  • HTA66 Modified Delphi Research to Seek Consensus on dRTA Disease Model, Treatment, and Management

    Jun 1, 2023, 00:00
  • Stakeholder Engagement in Designing Attributes for a Discrete Choice Experiment With Policy Implications: An Example of 2 Swiss Studies on Healthcare Delivery [Editor's Choice]

    Jun 1, 2023, 00:00
  • EPH27 Association between Prescribing Specialty and Treatment-Related Complications in Patients Using Novel Hormonal Agents for Metastatic Castration-Resistant Prostate Cancer: Population-Based Study

    Jun 1, 2023, 00:00
  • PCR82 Systematic Literature Review on the Value of Hemophilia Treatment in Japan

    Jun 1, 2023, 00:00
  • «
  • 21
  • 22
  • 23 (current)
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • »